In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
March 26th, 2006 | 16 | No |
Popular Name: methyl methyl
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 1.58 | 1.03 | -13.2 | 2 | 5 | 0 | 80 | 219.196 | 2 | ↓ |
Mid Mid (pH 6-8) | 1.58 | 1.79 | -37.02 | 1 | 5 | -1 | 82 | 218.188 | 2 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
LCK-3-E | Tyrosine-protein Kinase LCK (cluster #3 Of 4), Eukaryotic | Eukaryotes | 200 | 0.59 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
LCK_HUMAN | P06239 | Tyrosine-protein Kinase LCK, Human | 200 | 0.59 | Binding ≤ 1μM |
LCK_HUMAN | P06239 | Tyrosine-protein Kinase LCK, Human | 200 | 0.59 | Binding ≤ 10μM |
Description | Species |
---|---|
CD28 co-stimulation | |
CD28 dependent PI3K/Akt signaling | |
CD28 dependent Vav1 pathway | |
Constitutive PI3K/AKT Signaling in Cancer | |
CTLA4 inhibitory signaling | |
DAP12 signaling | |
Downstream TCR signaling | |
Generation of second messenger molecules | |
GPVI-mediated activation cascade | |
Interleukin-2 signaling | |
Nef and signal transduction | |
Nef Mediated CD4 Down-regulation | |
PD-1 signaling | |
PECAM1 interactions | |
Phosphorylation of CD3 and TCR zeta chains | |
PIP3 activates AKT signaling | |
Regulation of KIT signaling | |
Signaling by SCF-KIT | |
Translocation of ZAP-70 to Immunological synapse |